The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Aquaporin-4–binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2
Open accessAbstract
Neuromyelitis optica (NMO)-immunoglobulin G (IgG) is a clinically validated serum biomarker that distinguishes relapsing central nervous system (CNS) inflammatory demyelinating disorders related to NMO from multiple sclerosis. This autoantibody targets astrocytic aquaporin-4 (AQP4) water channels. Clinical, radiological, and immunopathological data suggest that NMO-IgG might be pathogenic. Characteristic CNS lesions exhibit selective depletion of AQP4, with and without associated myelin loss; focal vasculocentric deposits of IgG, IgM, and complement; prominent edema; and inflammation. The effect of NMO-IgG on astrocytes has not been studied. In this study, we demonstrate that exposure to NMO patient serum and active complement compromises the membrane integrity of CNS-derived astrocytes. Without complement, astrocytic membranes remain intact, but AQP4 is endocytosed with concomitant loss of Na+-dependent glutamate transport and loss of the excitatory amino acid transporter 2 (EAAT2) . Our data suggest that EAAT2 and AQP4 exist in astrocytic membranes as a macromolecular complex. Transport-competent EAAT2 protein is up-regulated in differentiating astrocyte progenitors and in nonneural cells expressing AQP4 transgenically. Marked reduction of EAAT2 in AQP4-deficient regions of NMO patient spinal cord lesions supports our immunocytochemical and immunoprecipitation data. Thus, binding of NMO-IgG to astrocytic AQP4 initiates several potentially neuropathogenic mechanisms: complement activation, AQP4 and EAAT2 down-regulation, and disruption of glutamate homeostasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Danbolt, N. C. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00067-8 · Cited by 4,227
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
Lennon, V. A., Kryzer, T. J., Pittock, S. J., Verkman, A. S., & Hinson, S. R. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050304 · Cited by 2,288
Self-citationThe spectrum of neuromyelitis optica
Wingerchuk, D. M., Lennon, V. A., Lucchinetti, C. F., Pittock, S. J., & Weinshenker, B. G. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70216-8 · Cited by 2,179
Self-citationNielsen, S., Arnulf Nagelhus, E., Amiry-Moghaddam, M., Bourque, C., Agre, P., & Petter Ottersen, O. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-01-00171.1997 · Cited by 1,442
A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica
Lucchinetti, C. F. (2002) · Brain · doi:10.1093/brain/awf151 · Cited by 1,210
Self-citationChaudhry, F. A., Lehre, K. P., Lookeren Campagne, M. V., Ottersen, O. P., Danbolt, N. C., & Storm-Mathisen, J. (1995) · Neuron · doi:10.1016/0896-6273(95)90158-2 · Cited by 826
Glutamate excitotoxicity in a model of multiple sclerosis
Pitt, D., Werner, P., & Raine, C. S. (2000) · Nature Medicine · doi:10.1038/71555 · Cited by 744
Roemer, S. F., Parisi, J. E., Lennon, V. A., Benarroch, E. E., Lassmann, H., Bruck, W., Mandler, R. N., Weinshenker, B. G., Pittock, S. J., Wingerchuk, D. M., et al. (2007) · Brain · doi:10.1093/brain/awl371 · Cited by 716
Self-citationNeuromyelitis Optica and Non–Organ-Specific Autoimmunity
Pittock, S. J., Lennon, V. A., de Seze, J., Vermersch, P., Homburger, H. A., Wingerchuk, D. M., Lucchinetti, C. F., Zéphir, H., Moder, K., & Weinshenker, B. G. (2008) · Archives of Neurology · doi:10.1001/archneurol.2007.17 · Cited by 608
Self-citationNMDA receptors are expressed in developing oligodendrocyte processes and mediate injury
Salter, M. G., & Fern, R. (2005) · Nature · doi:10.1038/nature04301 · Cited by 553
Mcdonald, J. W., Althomsons, S. P., Hyrc, K. L., Choi, D. W., & Goldberg, M. P. (1998) · Nature Medicine · doi:10.1038/nm0398-291 · Cited by 544
Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica
Hinson, S. R., Pittock, S. J., Lucchinetti, C. F., Roemer, S. F., Fryer, J. P., Kryzer, T. J., & Lennon, V. A. (2007) · Neurology · doi:10.1212/01.wnl.0000289761.64862.ce · Cited by 494
Self-citationNMDA receptor pathways as drug targets
Kemp, J. A., & McKernan, R. M. (2002) · Nature Neuroscience · doi:10.1038/nn936 · Cited by 476
Autoimmune encephalomyelitis ameliorated by AMPA antagonists
Smith, T., Groom, A., Zhu, B., & Turski, L. (2000) · Nature Medicine · doi:10.1038/71548 · Cited by 467
Danbolt, N. C., Storm-Mathisen, J., & Kanner, B. I. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90316-t · Cited by 436
Louis, J. C., Magal, E., Muir, D., Manthorpe, M., & Varon, S. (1992) · Journal of Neuroscience Research · doi:10.1002/jnr.490310125 · Cited by 414
The link between excitotoxic oligodendroglial death and demyelinating diseases
Matute, C., Alberdi, E., Domercq, M., Pérez-Cerdá, F., Pérez-Samartı́n, A., & Sánchez-Gómez, M. V. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01746-x · Cited by 348
Expression of complement in the brain: role in health and disease
Morgan, B. P., & Gasque, P. (1996) · Immunology Today · doi:10.1016/0167-5699(96)20028-f · Cited by 230
Modulation of the neuronal glutamate transporter EAAC1 by the interacting protein GTRAP3-18
Lin, C.-L. G., Orlov, I., Ruggiero, A. M., Dykes-Hoberg, M., Lee, A., Jackson, M., & Rothstein, J. D. (2001) · Nature · doi:10.1038/35065084 · Cited by 228
The distribution of Ia antigen in the lesions of rat acute experimental allergic encephalomyelitis
Vass, K., Lassmann, H., Wekerle, H., & Wisniewski, H. M. (1986) · Acta Neuropathologica · doi:10.1007/bf00691433 · Cited by 213
Aquaporin-4 deficiency down-regulates glutamate uptake and GLT-1 expression in astrocytes
Zeng, X.-N., Sun, X.-L., Gao, L., Fan, Y., Ding, J.-H., & Hu, G. (2007) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2006.09.008 · Cited by 183
Glutamate Receptor Expression in Multiple Sclerosis Lesions
Newcombe, J., Uddin, A., Dove, R., Patel, B., Turski, L., Nishizawa, Y., & Smith, T. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00101.x · Cited by 164
Preferential spinal central gray matter involvement in neuromyelitis optica: An MRI study
Nakamura, M., Miyazawa, I., Fujihara, K., Nakashima, I., Misu, T., Watanabe, S., Takahashi, T., & Itoyama, Y. (2008) · Journal of Neurology · doi:10.1007/s00415-008-0545-z · Cited by 142
Grossniklaus, H. E. (2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(02)01786-5 · Cited by 121
Activation of Kainate Receptors Sensitizes Oligodendrocytes to Complement Attack
Alberdi, E. M., Sánchez‐Gómez, M. V., Torre, I., Domercq, M., Pérez‐Samartín, A., Pérez‐Cerdá, F., & Matute, C. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3780-05.2006 · Cited by 96
Pharmacology of Sodium‐Dependent High‐Affinity l ‐[3H]Glutamate Transport in Glial Cultures
Garlin, A. B., Sinor, A. D., Sinor, J. D., Jee, S. H., Grinspan, J. B., & Robinson, M. B. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64062572.x · Cited by 82
Jensen, A. A., & Bräuner‐Osborne, H. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.02.013 · Cited by 72
Stanimirovic, D. B., Ball, R., Small, D. L., & Muruganandam, A. (1999) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(99)00028-3 · Cited by 64
On How Altered Glutamate Homeostasis May Contribute to Demyelinating Diseases of the Cns
Matute, C., Domercq, M., Fogarty, D. J., de Zulueta, M. P., & Sánchez‐Gómez, M. V. (1999) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4685-6_8 · Cited by 24
Regional Distribution of Sodium-Dependent Excitatory Amino Acid Transporters in Rat Spinal Cord
Queen, S. A., Kesslak, J. P., & Bridges, R. J. (2007) · Journal of Spinal Cord Medicine · doi:10.1080/10790268.2007.11753935 · Cited by 18
Cited by
Myelin in the Central Nervous System: Structure, Function, and Pathology
Stadelmann, C., Timmler, S., Barrantes-Freer, A., & Simons, M. (2019) · Physiological Reviews · doi:10.1152/physrev.00031.2018 · Cited by 728
Aquaporin 4 and neuromyelitis optica
Papadopoulos, M. C., & Verkman, A. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70133-3 · Cited by 597
Molecular pathophysiology of cerebral edema
Stokum, J. A., Gerzanich, V., & Simard, J. M. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x15617172 · Cited by 587
Glial influence on the blood brain barrier
Alvarez, J. I., Katayama, T., & Prat, A. (2013) · Glia · doi:10.1002/glia.22575 · Cited by 544
Serologic diagnosis of NMO: A multicenter comparison of aquaporin-4-IgG assays
Waters, P. J., McKeon, A., Leite, M. I., Rajasekharan, S., Lennon, V. A., Villalobos, A., Palace, J., Mandrekar, J. N., Vincent, A., Bar-Or, A., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e318248dec1 · Cited by 526
Self-citation
Metadata
- Authors
- Hinson, S. R., Roemer, S. F., Lucchinetti, C. F., Fryer, J. P., Kryzer, T. J., Chamberlain, J. L., Howe, C. L., Pittock, S. J., & Lennon, V. A.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2008-10-06
- Volume
- 205
- Issue
- 11
- Pages
- 2473-2481
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2123936058
- Cited by
- 355
- References
- 30
- FWCI
- 17.48
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.